Lexicon Pharmaceuticals
LXRX
#6255
Rank
$1.02 B
Marketcap
$2.31
Share price
-1.28%
Change (1 day)
115.89%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Net assets

Net assets on the balance sheet as of March 2026 : $0.20 Billion USD

According to Lexicon Pharmaceuticals 's latest financial reports the company has $0.20 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lexicon Pharmaceuticals - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$$0.10 B-26.32%
2024-12-31$$0.14 B56.75%
2023-12-31$$93.11 M-20.5%
2022-12-31$$0.11 B3.11%
2021-12-31$$0.11 B-27.36%
2020-12-31$$0.15 B33.54%
2019-12-31$$0.11 B-543.48%
2018-12-31$-$26.41 Million-138.68%
2017-12-31$$68.26 M-56.63%
2016-12-31$$0.15 B-44.94%
2015-12-31$$0.28 B0.65%
2014-12-31$$0.28 B66.91%
2013-12-31$$0.17 B-36.19%
2012-12-31$$0.26 B-10.38%
2011-12-31$$0.29 B20.46%
2010-12-31$$0.24 B51.09%
2009-12-31$$0.16 B-16.51%
2008-12-31$$0.19 B-31.67%
2007-12-31$$0.28 B235.17%
2006-12-31$$85.5 M-0.35%
2005-12-31$$85.8 M-29.44%
2004-12-31$$0.12 B-26.85%
2003-12-31$$0.16 B-2.17%
2002-12-31$$0.16 B-22.2%
2001-12-31$$0.21 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Thermo Fisher Scientific
TMO
$52.06 B 25,564.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$2.67 B 1,219.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$31.42 B 15,390.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-$0.23 Billion-212.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$0.99 B 391.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-$0.31 Billion-251.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-$0.17 Billion-180.84%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$6.21 B 2,962.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
$6.85 M-96.62%๐Ÿ‡บ๐Ÿ‡ธ USA